Navigation Links
Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D.
Date:1/24/2011

FRAZER, Pa., Jan. 24, 2011 /PRNewswire/ -- Cephalon, Inc., (Nasdaq: CEPH) will hold a public memorial service to celebrate the life of the company's founder and late Chairman and CEO on February 1, 2011, at 6:00 p.m. at The Franklin Institute, 222 North 20th Street, Philadelphia, Pennsylvania.

Dr. Baldino founded Cephalon in 1987 and led the company from a privately held startup to one of the top ten biotechnology companies in the world. He was a recognized pioneer in the biotechnology industry; but, his most enduring legacy will be his accomplishments as a civic leader, a mentor, a philanthropist, and most notably, a husband and father.

Dr. Baldino died on December 16, 2010, from complications associated with leukemia. He was 57 years old.

Visit http://www.cephalon.com/frankbaldinojr/ to view Dr. Baldino's obituary, donate to a cause in his honor, view additional details about the memorial service, and pay tribute to him on an online memorial.  

About Cephalon, Inc.Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at http://www.cephalon.com/Media contacts:Fritz BittenbenderVice President, Public AffairsT: 610-883-5855Fbittenb@cephalon.comNatalie de VaneSr.  Director, Corporate Communications & Public AffairsT: 610-727-6536C: 484-319-3722ndevane@cephalon.com
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D.
2. Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely
3. Cephalon Reports Record Earnings and Raises 2010 Guidance
4. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
5. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
6. Cephalon Completes Acquisition of Arana Therapeutics
7. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
8. Cephalon Quarterly Conference Call Invitation
9. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
10. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
11. Cephalons New Product Launches Pace Record 2008 Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., a ... announce the issuance of a new patent covering a ... by the U.S. Patent and Trademark Office on May ... of the Buzz of Bio award in 2014 in ... to developing non-drug approaches to chronic disease. Renadylâ„¢, the ...
(Date:6/19/2017)... ... 19, 2017 , ... As Vice President, Product Services, Mr. ... implementation, support, and client process and SOP development. , Mr. Guinter brings a ... roles for service providers and top-tier pharmaceuticals, and as an independent consultant supported ...
(Date:6/16/2017)... Lexington, Massachusetts (PRWEB) , ... June 16, 2017 ... ... in medical device compliance and commercialization, has just announced two more sessions of ... of the series will focus on the world of online templates for design ...
(Date:6/15/2017)... ... June 15, 2017 , ... Cybrexa ... Series B round of financing in the amount of $6 million. An investment ... participated in the round. , The Series B funding will enable Cybrexa to ...
Breaking Biology Technology:
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
Breaking Biology News(10 mins):